OHLCX Market Research
Delayed

REGN

Regeneron is a biotechnology company that discovers, develops, and manufactures innovative medicines for serious diseases.

−2.75 (−0.30%) Nov 20, 2026 17:21 ET Delayed
Open
930.51
High
948.42
Low
916.66
Prev close
923.34
Volume
851K
Avg vol 10
894K

Today · Market closed · opens Mon 9:30 AM

Price

REGN chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 920.59

Strong sellNeutralStrong buy
Neutral
score −0.06 · 18 signalling
4Buy
9Neutral
5Sell

No clear lean. 4 buy, 9 neutral and 5 sell across 18 signals. Stoch RSI sits in oversold territory. Trend strength is strong (ADX 39).

How to read this →

Trend

MACD 12, 26, 9
Below signal line, still above zero
MACD 33.52 · Signal 37.95 · Hist −4.43
Sell
ADX 14
Strong trend, +DI ahead
ADX 39.47 · +DI 31.81 · −DI 15.90
Buy
Parabolic SAR 0.02, 0.2
Above price, 53.62 over the close
974.21
Sell
Ichimoku 9, 26, 52
Price above cloud, conversion above base
Conv 939.92 · Base 886.28 · A 766.76 · B 790.68
Buy

Momentum

RSI 14
Mid-range, no extreme
57.23
Neutral
Stoch 14, 3
Low, %K still below %D
%K 32.05 · %D 45.49
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K still below %D
%K 2.46 · %D 13.26
Neutral
Williams %R 14
Mid-range, falling
−67.95
Neutral
CCI 14
Negative, above −100
−39.17
Neutral
MFI 14
Below midpoint, not oversold
37.41
Neutral
ROC 12
Price down 1.08% over 12 bars
−1.08%
Sell
AO 5, 35
Above zero, falling
95.81
Neutral
TRIX 18
Above zero
0.590
Buy
KST 10/15/20/30, 3
Below its signal line
KST 187.49 · Signal 190.03
Sell

Volatility

Bollinger 20, 2
Upper half, %b 0.54
Up 1,018.96 · Mid 912.90 · Low 806.84
Neutral
Keltner 20, 10, 1.5
Inside the channel, upper half
Up 954.88 · Mid 908.59 · Low 862.30
Neutral

Volume

VWAP 345-bar
Close 31.7% above VWAP
698.86
Buy
Force Index 1
Negative, sellers in control
−2.4M
Sell
ATR
30.27
3.29% of close
A/D Line
1.7M
cumulative
OBV
8.5M
cumulative
Volume Profile
734.17 – 766.37
POC · bull 42.3M · bear 39.9M · 51 / 49
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

12.40%

Change in value over the past month.

3 month return

11.13%

Change in value over the last three months.

Max drawdown

26.05%

Largest fall from a peak to the low that followed.

Standard deviation

34.06%

How far daily returns stray from their average, annualised.

Sharpe ratio

0.73

Return above the risk-free rate per unit of volatility.

Calmar ratio

0.96

Annualised return against the maximum drawdown.

About

REGN summary

Loading summary…

Questions

REGN, answered

What are some key products developed by Regeneron?

Key products include EYLEA (for eye diseases), Dupixent (for asthma and eczema), and Libtayo (for skin cancer).

What is Regeneron’s commitment to research?

Regeneron invests heavily in research and development, with a focus on genetic and molecular medicine to treat serious diseases.

How can I invest in Regeneron Pharmaceuticals?

You can invest in Regeneron by purchasing shares through a brokerage account or investing in funds that include REGN stock.

Is Regeneron publicly traded?

Yes, Regeneron is publicly traded on the NASDAQ under the ticker symbol REGN.

How does Regeneron handle clinical trials?

Regeneron conducts extensive clinical trials to test the safety and efficacy of its drugs before seeking regulatory approval.

What is Regeneron’s role in COVID- treatment?

Regeneron developed monoclonal antibody treatments for COVID-19, which have been authorized for emergency use.

Where can I find more information about Regeneron?

More information can be found on Regeneron’s official website, in investor relations sections, and through financial news sources.

How does Regeneron approach drug development?

Regeneron utilizes its proprietary VelociSuite technologies to develop new therapeutic candidates efficiently.

What is the significance of Regeneron being a biotech company?

As a biotech company, Regeneron focuses on the development of drugs that are often targeted therapies for complex diseases.

How does Regeneron ensure access to its medicines?

Regeneron works with healthcare providers and payers to ensure its medications are accessible and affordable.

News

REGN in the news

Reveal Your REGN Trading Now

Discover unparalleled trading insights with OHLCX. Our automated system offers advanced analysis and technical indicators for REGN, aimed at optimizing your trading decisions. Boost your investment success with us and get ahead in the market now!

Boost Performance Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.